期刊文献+

大肠癌c-erbB-2、EGFR及p21^(ras)蛋白共同表达与肿瘤细胞增殖 被引量:5

Co-expression of c-erbB-2, EGFR and p21^(ras) protein in colorectal carcinoma as related to proliferation of the tumor cell
下载PDF
导出
摘要 目的:探讨c-erbB-2、EGFR及p21ras癌基因蛋白共同表达对大肠癌细胞增殖的影响。方法:应用免疫组化ABC法检测c-erbB-2、EGFR及p21ras蛋白在69例大肠癌中的表达情况,同时计数肿瘤细胞PCNA增殖指数。结果:3种癌基因蛋白全部阳性,c-erbB-2和EGFR同时阳性及单独。erbB-2阳性的大肠癌,癌细胞PCNA指数高于3种蛋白全部阴性组(P<0.05)。结论:c-erbB-2、EGFR和p21ras蛋白共同表达以及c-erbB-2和EGFR共同表达可能对大肠癌细胞的增殖有协同促进作用。 Purpose To study the influence between co-expression of c-erbB-2, EGFR and p21ras protein incolorectal carcinomas and proliferation of the tumor cells. Methods The expression of c-erbB-2, EGFR andp21ras protein were studied by immunohistochemical technique(ABC method) in 69 cases of colorectal carcinoma.Results The index of PCNA in carcinomas of the co-expression of c-erbB-2, EGFR and p21 protein, c-erbB-2co-expression with EGFR or c-erbB-2 expression was higher than that in those without any expression(P <0. 05). Conclusion There are high rate of tumor cell proliferation in the co-expression of c-erbB-2, EGFR andp21ras protein, and the co-expression of c-erbB-2 and EGFR.
作者 吴永平 柳红
出处 《临床与实验病理学杂志》 CAS CSCD 1999年第6期513-514,共2页 Chinese Journal of Clinical and Experimental Pathology
关键词 大肠肿瘤 C-ERBB-2 EGFR P21^RAS 细胞增殖 colonic neoplasms rectal neoplasms c-erbB-2 EGFR P21^(ras) protein PCNA immunohistochemistry
  • 相关文献

参考文献1

  • 1陈诗书,医学细胞与分子生物医学,1995年,504页

同被引文献40

  • 1苏勤,刘彦仿.c-erbB-2蛋白和表皮生长因子受体在肝脏病变中的表达[J].中华病理学杂志,1995,24(2):93-95. 被引量:15
  • 2施作霖,陈天水.乳腺癌免疫组化研究进展[J].临床与实验病理学杂志,1995,11(4):330-333. 被引量:14
  • 3Vang R, Cooley LD, Harrison WR, et al. Immunohistochemieal deterruination of HER-2/neu expression in invasive breast carcinoma[ J]. Am J Clin Pathol,2000 ,113 ( 5 ) :669 - 674.
  • 4Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network [J]. Nat Rev Mol Cell Biol,2001,2(2) :127 - 137.
  • 5Klapper LN, Waterman H, Sela M, et al. Tumor-inhibitory antibodies to HER-2/ErhB-2 may act by recruiting c-Cb1 and enhancing ubiquitination of HER-2 [ J ]. Cancer Res,2000,60 ( 13 ) : 3384 - 3388.
  • 6McKay JA, Murray LJ, Curran S, et al. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases[ J]. Eur J Cancer,2002,38 ( 17 ) :2258 - 2264.
  • 7Tong WM, Ellinger A, Sheinin Y, et al. Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells [ J]. Br J Cancer,1995,77(11 ) :1792 - 1798.
  • 8Silvestri GA, Rivera MP. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists [ J ]. Chest, 2005,128 ( 6 ) :3975 - 3984.
  • 9Di Carlo A, Mariano A, D'Alessandro V, et al. Evaluation of epidermal growth factor receptor, carcinoembryonie antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias[J]. Oncol Rep,2001,8(2) :387 -392.
  • 10Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage Ⅳ colon adenocarcinoma: implications for a standardized scoring system[ J]. Cancer,2001,92 ( 5 ) : 1331 - 1346.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部